On call: Overseas demand hits new highs for skilled Indian nurses

It's a long way from Tirupati to Schwaighofstraße in Munich, but for 24-year-old Sushma Sree Eri, her dream destination is now within arm's reach. A BSc in Nursing, Sushma has landed a job in a German nursing home through
BorderPlus
, and is just awaiting the results of her B2 level German language test before she heads out.
Her initial pay will be 2,700 euros (about Rs 2.6 lakh) a month, which will increase to 3,300 euros (Rs 3.2 lakh) once she gets licensed there. That's compared to Rs 20,000-40,000 monthly she would have earned in a private hospital in India, and Rs 80,000 had she managed to get a government job.
Opportunities galore are opening up for Indian nurses in overseas markets as ageing developed economies increasingly need skilled professionals in critical, geriatric, paediatric and prenatal care amid a global healthcare workforce shortage.
Play Video
Pause
Skip Backward
Skip Forward
Unmute
Current Time
0:00
/
Duration
0:00
Loaded
:
0%
0:00
Stream Type
LIVE
Seek to live, currently behind live
LIVE
Remaining Time
-
0:00
1x
Playback Rate
Chapters
Chapters
Descriptions
descriptions off
, selected
Captions
captions settings
, opens captions settings dialog
captions off
, selected
Audio Track
default
, selected
Picture-in-Picture
Fullscreen
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
Text
Color
White
Black
Red
Green
Blue
Yellow
Magenta
Cyan
Opacity
Opaque
Semi-Transparent
Text Background
Color
Black
White
Red
Green
Blue
Yellow
Magenta
Cyan
Opacity
Opaque
Semi-Transparent
Transparent
Caption Area Background
Color
Black
White
Red
Green
Blue
Yellow
Magenta
Cyan
Opacity
Transparent
Semi-Transparent
Opaque
Font Size
50%
75%
100%
125%
150%
175%
200%
300%
400%
Text Edge Style
None
Raised
Depressed
Uniform
Drop shadow
Font Family
Proportional Sans-Serif
Monospace Sans-Serif
Proportional Serif
Monospace Serif
Casual
Script
Small Caps
Reset
restore all settings to the default values
Done
Close Modal Dialog
End of dialog window.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Air conditioners without external unit. (click to see prices)
Air Condition | Search Ads
Search Now
Undo
An estimated 70,000-100,000 Indian nurses migrated overseas last year and demand is set to increase 15-30% this year, according to industry executives. The momentum is likely to continue for several years, they said, as Germany, Italy and Japan are hiring Indian nurses in big numbers now, while traditional Organization for Economic Co-operation and Development (OECD) destinations including the UK, US, Australia and Canada, and Gulf countries such as Saudi Arabia, the UAE and Qatar, remain major employers.
(Join our
ETNRI WhatsApp channel
for all the latest updates)
'It's the best time ever to be a nurse,' said Deepesh Gupta, director – general staffing, Adecco, a global provider of human resources solutions.
Live Events
Around 640,000 Indian nurses are working abroad, including about 88,000 in OECD countries. There has been a notable surge since 2020, with an estimated 250,000-300,000 Indian nurses securing jobs overseas during this period, as per industry reports and government data from agencies like the Overseas Development and Employment Promotion Consultants.
Such is the potential that several big players have entered what was a largely unorganised segment.
BorderPlus, a talent mobility platform looking to connect blue-collar workers with global opportunities, starting with the healthcare sector in Germany, was launched by upGrad cofounder Mayank Kumar in January. Business services provider Quess has initiated efforts in the international nurse deployment space while talent company Randstad is working closely with government bodies from this fiscal to explore possibilities of facilitating the process of exporting nursing talent to high-demand countries.
BorderPlus has seen a 20–30% month-on-month increase in demand for
Indian nurses overseas
since its launch, according to its CEO Mayank Kumar. The growth trajectory suggests that over a year, the demand could potentially double, he said, adding that the surge is driven by the global shortage of nursing professionals, which the World Health Organization projects to reach 4.5 million by 2030.
'High-income countries are increasingly addressing this gap by recruiting from India, drawn by the reputation of Indian nurses for empathy, robust clinical skills, and comprehensive BSc-level training. These attributes make Indian nurses highly valued in healthcare systems worldwide,' said Kumar.
Demand up, requirements eased
Many countries have eased recruitment norms specifically for Indian professionals.
For instance, Germany plans to raise its skilled-worker visa cap from 20,000 to 90,000 for Indians, while Japan has simplified visa processes and offers eight to 10 times more pay than that in India. In addition, several countries are offering permanent residency or citizenship as part of their nurse recruitment strategies. Italy aims to recruit 10,000 Indian nurses in the coming years.
'Countries such as Australia, New Zealand and Canada have relaxed immigration requirements, providing streamlined visa pathways and bridging programmes,' said Adecco's Gupta.
Ireland issued 12,000 healthcare work permits in 2024, a significant share of which were granted to Indian professionals, said Sanjay Shetty, chief business officer - Quess Recruitment and International Services.
TeamLease chairman Manish Sabharwal, cofounder of Global Access to Talent from India (GATI) said there's potential for 500,000 Indian nurses to go abroad yearly on well-designed guest worker programmes. GATI, a non-profit foundation launched by The Convergence, Sabharwal and Godrej Foundation earlier this month, focuses on creating an enabling ecosystem for overseas employment from India.
Higher pay, better quality of life
Overseas nursing roles have become increasingly attractive to qualified Indians as they offer not just significantly higher pay but personal security, better quality of life and professional growth, said Quess' Shetty.
Indian nurses get seven to ten times higher pay packages abroad on average compared to the salaries in India, depending on their skill sets and levels of experience, said Shiv Nath Ghosh, chief commercial officer, professional talent solutions, Randstad India.
'In PPP (purchasing power parity) terms, these salaries often translate to 3-5x more effective income after adjusting for cost of living,' said BorderPlus' Kumar.
Shetty further said, 'A lot of countries abroad offer better workplaces, manageable patient-to-nurse ratios, regulated work hours and greater respect for the profession, leading to better job satisfaction and work-life balance.'

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Time of India

an hour ago

• Time of India

Tobacco trouble: Over 4,000 Rajasthan kids found buying tobacco in 2024-25; over 40,000 challans issued to curb smoking in public places

JAIPUR: Tobacco use among children and adolescents in Rajasthan persists despite well-known harmful effects of smoking and smokeless tobacco, the state's health department figures have shown. According to govt data, children not only frequently purchase tobacco products from local vendors, but issue is also exacerbated by the fact that sales often occur in close proximity to educational institutions, directly contravening existing laws. The Cigarette and Other Tobacco Products Act (COTPA) 2003 explicitly prohibits sale of tobacco products to individuals under 18 and restricts sales near educational institutions. However, enforcement has been inconsistent, with numerous cases of vendors caught selling tobacco to minors and operating within restricted zones. In 2024-25 alone, Rajasthan health dept issued 4,020 challans under various sections of the law for selling tobacco to minors and another 1,123 challans for sales near schools, highlighting the pervasive nature of the problem. While Rajasthan govt has received the national award for its rigorous enforcement of COTPA 2003, and the state has won top honours in the National Tobacco Control Programme for 2024-25, enforcement remains a challenge. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trending in in 2025: Local network access control [Click Here] Esseps Learn More Undo Principal Secretary (Health), Gayatri Rathore, said the govt launched the Tobacco-Free Educational Institution initiative in Sept 2024, under which it conducted 14,725 awareness programs and issued 40,232 challans under Section 4 of COTPA 2003 to curb smoking in public places. Additionally, 15,765 individuals received counselling, and 7,539 were treated for tobacco cessation, demonstrating a comprehensive approach to tackling the issue. However, gaps remain in the fight against tobacco use among youth, with continued public education and community engagement being crucial for reducing tobacco consumption among the youth.

Business Standard

3 hours ago

• Business Standard

Colgate-Palmolive to bring new global brands beyond oral care to India

Consumer goods manufacturer and oral care giant Colgate-Palmolive is looking to introduce more global brands in India in categories beyond oral care, a top executive told Business Standard on Monday. 'There are lots of brands globally that could be a good fit for India. We are in conversation to bring some of them to India. The portfolio has a lot of home care and personal care products that we think have potential in India,' Prabha Narasimhan, managing director and chief executive officer at Colgate-Palmolive, told Business Standard. The company's personal care business in the country has outpaced the category's growth rate of 20 per cent, she further said. Narasimhan was speaking to the media on the sidelines of the Oral Health Movement Summit in Delhi, an initiative launched by the company to help 4.5 million people screen their dental health and avail check-ups. Results from the screening show that almost 90 per cent of Indians face dental problems, with 41 per cent at risk of cavities, 44 per cent prone to gum issues, and 14 per cent prone to stains. According to Narasimhan, the consumption slowdown has impacted oral care categories too, along with other categories. 'The way we see the impact of the slowdown on a consumer changing their habits is not by stopping buying toothpaste or downtrading to lesser value products, but by titrating the amount of toothpaste they use per brush,' she said, adding that overall penetration of the category is not impacted. While the company's presence is skewed more towards the urban population, Narasimhan said that rural markets have been a bright spot — extremely buoyant in the last few quarters while outpacing urban. To drive urban growth, the company is betting big on premiumisation across categories. 'Another way is to make our core brands stronger to ensure that we are moving them forward in terms of the technology they offer and the benefits they deliver,' Narasimhan added. Meanwhile, the company witnessed its best year in the toothbrush category, 'driven by the availability of our Rs 20 and Rs 30 packs and selling more premium brushes in the modern trade channel. There continues to be definite headroom on both replacement and uptrading in the category,' she said. Colgate-Palmolive reported a 2 per cent year-on-year fall in revenue for the quarter ended March to Rs 1,452 crore, while its net profit declined 6.5 per cent for the same period to Rs 355 crore.

Mint

3 hours ago

• Mint

India€™s biotech sector grew nearly fivefold in past decade: DBT Secretary

New Delhi, Jun 23 (PTI) India's biotechnology sector has expanded rapidly in the past decade, with its bioeconomy growing from USD 35.5 billion in 2014 to USD 165.7 billion in 2024, according to Rajesh S Gokhale, Secretary, Department of Biotechnology (DBT). He said the sector is now aiming for a USD 300 billion target by 2030, as scientific advances begin to translate into industrial and public health gains. "Biotechnology is no longer a fringe discipline, it's now a strategic driver for India's economic and health priorities," Gokhale said at a press conference highlighting 11 years of DBT's achievements. Among the standout initiatives is GenomeIndia, a nationwide effort to sequence the genomes of 10,000 individuals from 99 population groups, he said. The data, released earlier this year, is expected to inform personalised medicine and help researchers develop diagnostics tailored to Indian populations. Gokhale also highlighted India's first in-human gene therapy trial using a lentiviral vector for Severe Hemophilia A. India's vaccine response, Gokhale said, demonstrated the capacity of the DBT-backed innovation ecosystem. Under "Mission COVID Suraksha", five COVID-19 vaccines developed with DBT support received emergency approvals, including GEMCOVAC-19, the world's first thermostable mRNA vaccine. Other products include the intranasal COVID-19 vaccine and CERVAVAC, India's first indigenous quadrivalent HPV vaccine, now part of the National Immunization Programme, according to document shared at the briefing. Indian scientists contributed to decoding the complex genome of bread wheat, a global staple crop, and published a reference genome with 94 per cent coverage. Other research showed how Mycobacterium tuberculosis can infect liver cells and undermine TB treatment efficacy, while a study on taurine levels suggested amino acid may influence aging. Gokhale said India's biotech startup landscape has changed dramatically, with over 10,000 startups now in the sector, up from a few hundred a decade ago. Over 800 biotech products have emerged in this period. Through BIRAC, DBT has helped set up 95 bio-incubators across 21 states. Infrastructure investments include India's first dedicated biomanufacturing institute in Mohali and vaccine testing labs notified as Central Drug Laboratories. Speed breeding facilities have also been established to accelerate the development of climate-resilient crops. The BioE3 policy, approved by the Cabinet in 2024, is aimed at fostering high-performance biomanufacturing aligned with Net Zero targets.